Kazia Therapeutics (KZIA) Total Liabilities (2009 - 2025)
Kazia Therapeutics (KZIA) posted Total Liabilities of $16.2 million for Q4 2025, up 75.94% on a QoQ basis from $9.2 million in Q2 2025, and up 13.93% year-over-year from $14.2 million in Q4 2024.
Kazia Therapeutics (KZIA) Total Liabilities (2009 - 2025) Analysis & Trends
Kazia Therapeutics' Total Liabilities history runs 17 years deep, the most recent figure standing at $16.2 million for Q4 2025.
- Quarterly Total Liabilities rose 13.93% year-over-year to $16.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.2 million (up 13.93% YoY) and the FY2025 annual result came in at $9.2 million, down 55.84% from the prior year.
- Total Liabilities was $16.2 million for Q4 2025 at Kazia Therapeutics, up from $9.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $20.8 million in Q2 2024 and bottomed at $9.2 million in Q2 2025.
- A 5-year average of $13.6 million and a median of $13.3 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2021 — Total Liabilities jumped 166.02% — and 2025, when it plunged 55.84%.
- Kazia Therapeutics' Total Liabilities stood at $14.0 million in 2021, then fell by 23.56% to $10.7 million in 2022, then advanced by 16.54% to $12.4 million in 2023, then advanced by 14.14% to $14.2 million in 2024, then climbed by 13.93% to $16.2 million in 2025.
- Business Quant data shows KZIA's Total Liabilities at $16.2 million in Q4 2025, $9.2 million in Q2 2025, and $14.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | 16.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.18 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Jun 30, 2024 | 20.83 Mn |
| Dec 31, 2023 | 12.44 Mn |
| Jun 30, 2023 | 10.72 Mn |
| Dec 31, 2022 | 10.68 Mn |
| Jun 30, 2022 | 12.62 Mn |
| Dec 31, 2021 | 13.97 Mn |
| Jun 30, 2021 | 15.58 Mn |
| Dec 31, 2020 | 5.80 Mn |
| Jun 30, 2020 | 5.86 Mn |
| Dec 31, 2019 | 5.63 Mn |
| Jun 30, 2019 | 4.89 Mn |
| Dec 31, 2018 | 5.19 Mn |
| Jun 30, 2018 | 6.76 Mn |
| Jun 30, 2017 | 7.94 Mn |
| Dec 31, 2016 | 9.04 Mn |
| Jun 30, 2016 | 7.89 Mn |
| Dec 31, 2015 | 1.28 Mn |